Navigation Links
Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association

SAFE digital identity and signature standard being adopted worldwide by pharmaceutical and healthcare organizations as secure method of confirming

digital identities

CHICAGO, Dec. 10 /PRNewswire-FirstCall/ -- Aladdin Knowledge Systems (Nasdaq: ALDN), an information security leader specializing in authentication, software DRM and content security, today announced that the Aladdin eToken strong authentication device is the first hardware product to be certified under the recently established SAFE(TM) Product Certification Program (SPCP). The program is administered by SAFE-BioPharma Association, a fast-growing industry group that developed and manages the SAFE(TM) digital identity standard for the pharmaceutical and healthcare industries.


Certification assures SAFE's members that the Aladdin eToken fully conforms to the SAFE digital identity and signature standard. SPCP imposes a rigorous self-testing process on SAFE Vendor Partner products in order to assess their compliance with the SAFE digital standard.

The SAFE Standard dramatically streamlines the pharmaceutical business and regulatory processes by allowing organizations to electronically verify the identities of all parties involved in numerous types of electronic transactions -- increasing security while also maximizing efficiency. Aladdin eToken's strong authentication technology allows SAFE members to easily apply the SAFE Standard to their day-to-day pharmaceutical business.

"We congratulate Aladdin on becoming the first SAFE Vendor Partner to use the new SAFE Product Certification Program to demonstrate that its product is compliant with the SAFE digital identity and signature standard. The company is to be congratulated for its vision and leadership," said Mollie Shields-Uehling, President and CEO, SAFE-BioPharma Association.

"As the first technology vendor to have a product certified by SAFE, Aladdin enjoys a leading role in providing strong authentication technologies to some of the most security-minded organizations in the industry," said Chen Arbel, vice president of strategic development at Aladdin. "By creating the keys on board the Aladdin eToken, we ensure the protection of data and prevent forgery in an industry that demands a consistent, secure method of confirming identities."

Aladdin eToken provides strong authentication for the pharmaceutical industry worldwide, meeting regulations such as those surrounding the European Union SSCD (Secure Signature Creation Device) that requires digital signatures to be hosted on a secure signature creation device such as Aladdin eToken.

About SAFE-BioPharma Association

SAFE-BioPharma Association is the non-profit association that created and manages the SAFE(TM) digital identity and digital signature standard for the pharmaceutical and healthcare industries. Through the SAFE standard, the association promotes interoperability and integration among researchers, vendors, regulators, clinicians and other pharmaceutical and healthcare stakeholders. The SAFE standard provides a secure, enforceable, and regulatory compliant way to verify the identities of parties involved in business-to-business and business-to-regulator electronic transactions. SAFE stands for "Signatures and Authentication For Everyone." The Association's members include Amgen, AstraZeneca, Bristol-Myers Squibb, Genzyme, GlaxoSmithKline, Johnson & Johnson, Merck, Pfizer, Procter & Gamble, Roche and Sanofi-Aventis. For more information, visit

About Aladdin eToken

Aladdin eToken is the world leader for USB-based authentication solutions. It provides strong user authentication and cost-effective password management solutions enabling organizations to easily and effectively expand business opportunities with secure network access, improve data security through enhanced encryption and digital signing, and reduce costs and vulnerabilities through superior password management. For more information, visit

About Aladdin

Aladdin Knowledge Systems' Software Rights Management products are the #1 choice of software developers and publishers to protect intellectual property, increase revenues, and reduce losses from software piracy. Aladdin eToken is the world's #1 USB-based authentication solution. The Aladdin eSafe secure Web gateway provides the most advanced protection against the latest Web-based threats and attacks. Aladdin has offices in 12 countries, a worldwide network of channel partners, and has won numerous awards for innovation. For more information, visit the Aladdin Web site at

SAFE(TM) is a trademark of SAFE-BioPharma Association. Any use of this trademark requires approval from SAFE-BioPharma Association.

(C)2007 Aladdin Knowledge Systems, Ltd. All rights reserved. eToken, Aladdin Knowledge Systems and the Aladdin logo are trademarks or registered trademarks of Aladdin Knowledge Systems, Ltd. All other product and brand names mentioned in this document are trademarks or registered trademarks of their respective owners.

Press Contact: Investor Relations Contact:

Matthew Zintel Erik Knettel / Andrea Costa

Zintel Public Relations Global Consulting Group

310.574.8888 646.284.9400

SOURCE Aladdin Knowledge Systems
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. First biomarker discovered that predicts prostate cancer outcome
2. FDA Approves First Anti-Psychotic for Kids
3. Single-incision belly-button surgery to remove kidney performed first at UT Southwestern
4. First study examines newly-licensed RN work attitudes and intentions
5. Glades General Hospital First in Palm Beach County to Provide On-Site Electronic Birth Registration
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
8. High and mighty: first common height gene identified by researchers behind obesity gene finding
9. APA Comments on FDAs First Approval of Medication to Treat Pediatric Schizophrenia and Bipolar Disorder
10. TriWest Creates First-of-its-Kind Partnership to Offer Military Leaders With Grief Support Program
11. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
Post Your Comments:
(Date:11/30/2015)... , ... November 30, 2015 , ... Cycling, running, and ... take on extra meaning the morning of February 28, 2016. , That’s when ... Park and thousands will exercise to help children and families at Joe DiMaggio ...
(Date:11/30/2015)... ... November 30, 2015 , ... A ... of bacteria could be effective in fighting methicillin-resistant Staphylococcus aureus (MRSA), one of ... Their study showed that small molecule analogs that target the functions of SecA, ...
(Date:11/30/2015)... ... November 30, 2015 , ... Using a combination of two blood ... children and adults, according to a new study by researchers at the School of ... Children and Adults: Using Combinations of Blood Glucose Tests ,” published in Frontiers in ...
(Date:11/30/2015)... ... November 30, 2015 , ... International telepathology consultations can ... and KingMed Diagnostics researchers. Their review of more than 1,500 pathology ... pathologists resulted in significantly altered treatment plans for more than half of the ...
(Date:11/30/2015)... PHILADELPHIA (PRWEB) , ... November 30, 2015 , ... ... Philadelphia-based non-profit promoting breast and prostate cancer education and prevention—is joining forces with ... evening of philanthropy and Hollywood elegance on December 7, 2015 at the Union ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... BOCA RATON, Fla. , Nov. 30, ... of Public Research (the Institute) announced today that ... , a medical device start-up company with technology developed ... creation based on publicly-funded research, and bridges early funding ... -based universities and research institutions. ...
(Date:11/30/2015)... Nov. 30, 2015 Baxalta Incorporated ... leader dedicated to delivering transformative therapies to ... conditions, today announced the launch and first ... an extended circulating half-life recombinant factor VIII ... full-length ADVATE [Antihemophilic Factor (Recombinant)]. The treatment ...
(Date:11/30/2015)... Months Ended 30 September 2015 2014RestatedChange%Turnover 545,575 , 518,852 , ... 384,242 , 9.8 Hospital Management Service Income ... (18.3) Medical Insurance Administration Service Income , 2,780 ... and Accessories Sales , 89,645 , 94,580 ... 2,822 , 2,917 , (3.3) Gross ...
Breaking Medicine Technology: